October 16th 2024
The addition of T4001, an investigation cancer vaccine, to avelumab did not improve progression-free survival vs avelumab alone in cervical and anogenital tumors.
October 8th 2024
The World Health Organization updated their guidelines to include CINtec PLUS Cytology for gynecologic cancer prevention.
September 15th 2024
Pembrolizumab plus chemoradiotherapy improved survival in patients with previously untreated, high-risk locally advanced cervical cancer.
August 19th 2024
Bintrafusp alfa induced responses in recurrent/metastatic cervical cancer, supporting the need for further research into TGF-β-targeted therapies.
May 26th 2024
A breakthrough device designation has been granted by the FDA to Teal Wand, an at-home screening test for cervical cancer.
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers
Mitazalimab Plus mFOLFIRINOX Improves Survival in Pancreatic Cancer
Novel ADC Shows Promise in Platinum-Resistant Ovarian Cancer
Chemo Should be Tailored to Decrease Neuropathy in Black Patients